BONUS! Stoa Policy Debate: Sandbox FDA (NEG)

This is where all download will be listed, utilizing the Page Add plugin.

File Name S22-Policy-Stoa-57-NEG-SandboxFDA.docx
File Size 64.49 KB
Date added February 23, 2022
Category Archived, Policy (Stoa)
Author Vance Trefethen

Resolved: The United States federal government substantially reform the use of Artificial Intelligence technology

Case Summary: The AFF plan : FDA work with Sandbox to “filter” stringent regulations and focus on regulations that actually apply to AI medical devices.   “Sandbox” is a scaled down regulatory approval process used to test new devices in a restricted, safe space (sandbox) differently from the normal testing and approval process.  AFF may claim that Britain (UK) and Indonesia are using it successfully today, and we have responses to both of those.  Scrutinize carefully any foreign evidence and make sure it’s talking about “Sandbox for artificial intelligence medical devices” and not just any kind of Sandbox.  Sandbox can also be used for testing of other critical systems, like financial industry software, and some of their solvency evidence may be coming from other industries like that.